Pfizer’s Lack of Integrity Central to Lipitor OTC Debate
Lipitor’s link to diabetes and Pfizer’s ongoing failures to disclose this risk must not be ignored in Pfizer’s quest to have its popular cholesterol-lowering drug […]
Pfizer’s Lack of Integrity Central to Lipitor OTC Debate Read More
